Relationship Between Porphyromonas Gingivalis and Obesity in Patients With Periodontitis

Obesity Clinical Trial

— PAROBIOTA  

Official title:

Non-interventional Study Exploring the Relationship Between Porphyromonas Gingivalis and Obesity in Patients With Periodontitis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05942703
• Other study ID #: RC31/20/0478
• Status: Recruiting
• Start date: December 5, 2022
• Est. completion date: December 30, 2024

Study information

• Verified date: July 2023
• Source: University Hospital, Toulouse
• Contact: Sara LAURENCIN, MD
• Phone: 0561344473
• Email: laurencin.s[@]chu-toulouse.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Obesity is recognized as a major public health problem. Recent research suggests the involvement of the gut microbiota in the development of obesity. Indeed, obese people are characterized by a dysbiotic intestinal microbiota. Periodontitis are chronic inflammatory oral pathologies linked to an imbalance between the bacterial etiological factor, oral dysbiosis, and the host's immune defenses.They lead to the destruction of the supporting tissues of the tooth and an apical migration of the periodontal attachment system, thus leading to the formation of the pathognomonic entity of the disease, the periodontal pocket.the presence of bacteria of oral origin such as Porphyromonas gingivalis (Pg) has been demonstrated in the adipose tissue of obese patients inducing a chronic low-grade inflammatory response by macrophages which leads to the proliferation of adipocyte precursors predisposing to obesity. The main objective is to assess the average amount of Porphyromonas gingivalis (Pg) in the saliva of obese people (BMI ≥ 30) with periodontitis.

Description:

Obesity is recognized as a major public health problem. Recent research suggests the involvement of the gut microbiota in the development of obesity. Indeed, obese people are characterized by a dysbiotic intestinal microbiota. Periodontitis are chronic inflammatory oral pathologies linked to an imbalance between the bacterial etiological factor, oral dysbiosis, and the host's immune defenses.They lead to the destruction of the supporting tissues of the tooth and an apical migration of the periodontal attachment system, thus leading to the formation of the pathognomonic entity of the disease, the periodontal pocket.the presence of bacteria of oral origin such as Porphyromonas gingivalis (Pg) has been demonstrated in the adipose tissue of obese patients inducing a chronic low-grade inflammatory response by macrophages which leads to the proliferation of adipocyte precursors predisposing to obesity. The main objective is to assess the average amount of Porphyromonas gingivalis (Pg) in the saliva of obese people (BMI ≥ 30) with periodontitis.This study is a comparative cross-sectional non-interventional study with retrospective and prospective and consecutive recruitment of participants. Prospective patient recruitment: During the patient's visit to the periodontology department, if the patient has periodontitis and has given his non-objection, he will be included in the study. A routine check-up in odontology will then be carried out: complete medical questionnaire (general, hygiene and dietetics), clinical examination (visual examination and statement of periodontal indices), radiological examination. Samples of saliva and periodontal plaque, conventionally taken in current dental surgery practice in the periodontal management of patients, will be used to carry out bacterial assays. CThe saliva samples, which are part of the usual treatment, will be carried out before and after the non-surgical periodontal treatment.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 311
• Est. completion date: December 30, 2024
• Est. primary completion date: March 27, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• over 18 years old
• having periodontitis
• able to receive information on the course of the study and to understand the information form to participate in the study.
• having given their non-objection to participate in the study

Exclusion Criteria:

• Having taken antibiotics, prebiotics or probiotics in the month prior to inclusion
• During pregnancy or breastfeeding
• With a history of oral surgery in the month prior to inclusion
• At risk of infection (existence of one or more known chronic infectious diseases)
• Suffering from a general pathology contraindicating the performance of diagnostic procedures such as periodontal probing (patients at high risk of infective endocarditis according to the French National Agency for the Safety of Medicines and Products of Health ANSM)

Related Conditions & MeSH terms

• Obesity
• Periodontitis

Intervention

Other:
• saliva samples
Saliva samples, which are part of the usual treatment, will be carried out before and after the non-surgical periodontal treatment

Locations

Country	Name	City	State
France	UHToulouse	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analysis by bacterial culture and taxonomic analysis (MiSEQ) of the microbiological composition of saliva	Assess the microbiological composition of saliva and periodontal plaque in obese (BMI=30) and non-obese (BMI<30) patients with periodontitis.	8 weeks
Primary	Analysis by bacterial culture and taxonomic analysis (MiSEQ) of the microbiological composition periodontal plaque	Assess the microbiological composition of periodontal plaque in obese (BMI=30) and non-obese (BMI<30) patients with periodontitis.	8 weeks